STEVE ASELAGE Insider Trading $ACER Acer Therapeutics Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVE ASELAGE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVE ASELAGE. STEVE ASELAGE is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and EVP, Global Commercial Ops in CTI BIOPHARMA CORP ($CTIC) and in Acer Therapeutics Inc. ($OPXA) and Director in Acer Therapeutics Inc. ($OPXA) and Chief Executive Officer in Retrophin, Inc. ($RTRX) and Director in Retrophin, Inc. ($RTRX).
STEVE ASELAGE in Acer Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVE ASELAGE: Director
Holdings: 63,905 shares
Current Value: $65,183
Latest Transaction: Jan 20 2021
$ACER Market Capitalization: $7.21M
$ACER Previous Close: $1.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STEVE ASELAGE in Acer Therapeutics Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACER, BCRX, CTIC, RTRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 20 2021 | ACER | Acer Therapeutics ... | ASELAGE STEVE | Director | Option Exercise | A | 3.85 | 15,000 | 57,750 | 15,000 | |
| Jul 28 2020 | ACER | Acer Therapeutics ... | ASELAGE STEVE | Director | Buy | P | 3.50 | 45,000 | 157,500 | 63,905 | 18.9 K to 63.9 K (+238.03 %) |
| Jan 03 2020 | ACER | Acer Therapeutics ... | ASELAGE STEVE | Director | Option Exercise | A | 3.79 | 9,000 | 34,110 | 9,000 | |
| Jul 05 2019 | ACER | Acer Therapeutics ... | ASELAGE STEVE | Director | Buy | P | 3.72 | 5,000 | 18,581 | 18,905 | 13.9 K to 18.9 K (+35.96 %) |
| Feb 05 2019 | ACER | Acer Therapeutics ... | ASELAGE STEVE | Director | Option Exercise | A | 24.46 | 6,000 | 146,760 | 6,000 | |
| Feb 05 2019 | ACER | Acer Therapeutics ... | ASELAGE STEVE | Director | Option Exercise | A | 24.46 | 6,000 | 146,760 | 6,000 | |
| Dec 18 2017 | OPXA | Acer Therapeutics ... | ASELAGE STEVE | Director | Buy | P | 12.00 | 2,000 | 24,000 | 13,905 | 11.9 K to 13.9 K (+16.80 %) |
| Oct 06 2017 | OPXA | Acer Therapeutics ... | ASELAGE STEVE | Option Exercise | A | 15.34 | 6,000 | 92,040 | 6,000 | ||
| Sep 21 2017 | OPXA | Acer Therapeutics ... | ASELAGE STEVE | Option Exercise | J | 2.55 | 21,000 | 53,550 | 21,000 | ||
| Sep 21 2017 | OPXA | Acer Therapeutics ... | ASELAGE STEVE | Buy | J | 0.00 | 11,905 | 0 | 11,905 | 0 to 11.9 K |
Page: 1